CEO Robin Vince highlighted a "solid financial performance" with earnings per share reaching $1.58, representing a 26% year-over-year increase. Total revenue reached $4.8 billion, up 6% year-over-year ...

Analyst upgrades American Express to Buy, lowers price target. Amex's high-quality customer base and spend-centric model may ...

Tata Consultancy Services (TCS) reported disappointing revenue and profit growth for the March quarter reflecting delay in ...

As health system revenue cycles grow increasingly complex, WVU Medicine is taking a bold step to unify its revenue cycle ...

Bilfinger has unveiled a comprehensive rebranding initiative designed to reinforce its role as the top industrial services partner for the proces ...

We think Foshan Haitian Flavouring and Food is in sound financial shape as it possesses abundant cash reserves and runs on very low leverage with minimal debt. The company has a debt/equity ratio of ...

MarketWise operates a content and technology multi-brand platform for self-directed investors in the United States and ...

Vertex Pharmaceuticals sees early success with Journavx painkiller, potential revenue growth from drug and gene therapy.

The rise in the Delhivery share price came after the company announced on April 5 that it had signed a definitive agreement ...